Reactive oxygen species drive epigenetic changes in radiation‐induced fibrosis
S Shrishrimal, EA Kosmacek… - … medicine and cellular …, 2019 - Wiley Online Library
Radiation‐induced fibrosis (RIF) develops months to years after initial radiation exposure.
RIF occurs when normal fibroblasts differentiate into myofibroblasts and lay down aberrant …
RIF occurs when normal fibroblasts differentiate into myofibroblasts and lay down aberrant …
[HTML][HTML] Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: pharmacology and mechanisms
X Li, L Li, W Lei, HZ Chua, Z Li, X Huang… - Biomedicine & …, 2021 - Elsevier
Cardiovascular diseases are one of the leading causes of death worldwide and cardiac
fibrosis is a common pathological process for cardiac remodeling in cardiovascular …
fibrosis is a common pathological process for cardiac remodeling in cardiovascular …
Curcumin protects against myocardial infarction-induced cardiac fibrosis via SIRT1 activation in vivo and in vitro
J Xiao, X Sheng, X Zhang, M Guo… - Drug design, development …, 2016 - Taylor & Francis
Curcumin, a polyphenolic compound derived from turmeric, protects against myocardial
injury by alleviating oxidative stress, inflammation, apoptosis, and fibrosis. However, the role …
injury by alleviating oxidative stress, inflammation, apoptosis, and fibrosis. However, the role …
Berberine attenuates myocardial ischemia/reperfusion injury by reducing oxidative stress and inflammation response: role of silent information regulator 1
L Yu, Q Li, B Yu, Y Yang, Z Jin, W Duan… - Oxidative Medicine …, 2016 - Wiley Online Library
Berberine (BBR) exerts potential protective effect against myocardial ischemia/reperfusion
(MI/R) injury. Activation of silent information regulator 1 (SIRT1) signaling attenuates MI/R …
(MI/R) injury. Activation of silent information regulator 1 (SIRT1) signaling attenuates MI/R …
The emerging role of HDACs: pathology and therapeutic targets in diabetes mellitus
Diabetes mellitus (DM) is one of the principal manifestations of metabolic syndrome and its
prevalence with modern lifestyle is increasing incessantly. Chronic hyperglycemia can …
prevalence with modern lifestyle is increasing incessantly. Chronic hyperglycemia can …
SIRT1 as a therapeutic target in diabetic complications
J Strycharz, Z Rygielska, E Swiderska… - Current medicinal …, 2018 - ingentaconnect.com
Background: Sirtuin1 is an epigenetic enzyme involved in histone and nonhistone protein
deacetylation. It acts primarily as a metabolic sensor, which responses to changing energy …
deacetylation. It acts primarily as a metabolic sensor, which responses to changing energy …
[HTML][HTML] Urolithin A prevents streptozotocin-induced diabetic cardiomyopathy in rats by activating SIRT1
G Albasher, S Alkahtani, LN Al-Harbi - Saudi journal of biological sciences, 2022 - Elsevier
This study examined the cardiac anti-cardiomyopathy (DC) protective effect of urolithin A in
streptozotocin (STZ)-treated rats and investigated if this protection involves activation of …
streptozotocin (STZ)-treated rats and investigated if this protection involves activation of …
[PDF][PDF] Kaempferol protects against streptozotocin-induced diabetic cardiomyopathy in rats by a hypoglycemic effect and upregulating SIRT1.
AS Alshehri, AF El-Kott, SM Eleawa… - Journal of Physiology …, 2021 - jpp.krakow.pl
This study investigated if kaempferol could attenuate the oxidative, inflammatory, and fibrotic
damage of the left ventricles (LVs) in streptozotocin (STZ)-diabetic rats by modulating silent …
damage of the left ventricles (LVs) in streptozotocin (STZ)-diabetic rats by modulating silent …
[HTML][HTML] Evidence of epigenetic tags in cardiac fibrosis
V Grimaldi, MR De Pascale, A Zullo, A Soricelli… - Journal of …, 2017 - Elsevier
In cardiac fibrosis, following an injury or a stress, non-functional fibrotic tissue substitutes
normal myocardium, thus leading to progressive heart failure. Activated fibroblasts are …
normal myocardium, thus leading to progressive heart failure. Activated fibroblasts are …
[PDF][PDF] Ellagic acid protects against diabetic cardiomyopathy in rats by stimulating cardiac silent information regulator 1 signaling
JZ Altamimi, NA Alfaris, GM Alshammari… - J Physiol …, 2020 - researchgate.net
This study investigated the protective effect of ellagic acid (EA) against diabetic
cardiomyopathy (DC) in streptozotocin (STZ)-treated rats and examined if the mechanism of …
cardiomyopathy (DC) in streptozotocin (STZ)-treated rats and examined if the mechanism of …